Pharmacokinetics of Verapamil and Norverapamil Enantiomers After Administration of Immediate and Controlled‐Release Formulations to Humans: Evidence Suggesting Input‐Rate Determined Stereoselectivity
Authors:
- 1 November 1995
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 35 (11) , 1076-1082
Abstract
Verapamil is a racemic calcium channel‐blocking drug that undergoes extensive hepatic first‐pass metabolism to an active metabolite, norverapamil. The enantiomers of verapamil and norverapamil have differing negative inotropic, chronotropic, and dromotropic activities and differing effects on vascular smooth muscles; the S‐enantiomers having greater activity. It is hypothesized that the R/S concentration ratio of verapamil enantiomers may be input‐rate dependent. The pharmacokinetics of verapamil and norverapamil enantiomers were studied in 11 young, healthy male and female volunteers after oral administration of 80 mg immediate‐release (IR) verapamil every 8 hours, and a 240 mg dose once daily of controlled‐release (CR) formulation on two separate occasions. Both dosage regimens were continued for 1 week with a minimum 1‐week period between the two drug treatments. After the last dose of each regimen, plasma samples were collected over the period corresponding to the dosing interval. Enantiomer concentrations were determined using a microwave‐facilitated precolumn derivatization with high performance liquid chromatographic quantification. Stereospecific assay revealed that: (1) stereoselective R‐ and S‐enantiomer disposition occurred regardless of formulation administered; (2) a trend of R:S concentration ratios of verapamil differed between the two formulations; and (3) fluctuations between Cmaxand Cminvalues of the two formulations were statistically different over respective dosing intervals (greater fluctuation after CR administration). Using nonstereospecific data analyses, however, the pharmacokinetic parameters for verapamil and norverapamil were similar for both formulations over a 24‐hour period. We suggest that kinetic differences can be attributed to differences in release rates of drug from the tablet matrices. The relative bioavailabilities of verapamil and norverapamil from the two products may, therefore, be subject to input rate‐dependent processes.Keywords
This publication has 35 references indexed in Scilit:
- Evidence of absorption rate dependency of ibuprofen inversion in the ratChirality, 1994
- Stereospecific determination of the in vitro dissolution of modified release formulations of (±)-verapamilChirality, 1993
- Input rate‐dependent stereoselective pharmacokinetics: Enantiomeric oral bioavailability and blood concentration ratios after constant oral inputBiopharmaceutics & Drug Disposition, 1992
- Human Pharmacokinetics of Ibuprofen Enantiomers following Different Doses and Formulations: Intestinal Chiral InversionJournal of Pharmaceutical Sciences, 1992
- Pharmacodynamic Profile of Verapamil in Relation to Absolute BioavailabilityJournal of Cardiovascular Pharmacology, 1991
- On-line determination and resolution of verapamil enantiomers by high-performance liquid chromatography with column switchingJournal of Chromatography A, 1991
- Chiral aspects of drug action at ion channels: A commentary on the stereoselectivity of drug actions at voltage‐gated ion channels with particular reference to verapamil actions at the Ca2+ channelChirality, 1991
- Stereoselective protein binding of verapamil enantiomersBiochemical Pharmacology, 1988
- Specific HPLC Method for the Separation of Verapamil and Four Major Metabolites After Oral DosingJournal of Liquid Chromatography, 1988
- Clinical Pharmacokinetics of VerapamilClinical Pharmacokinetics, 1984